Menu

Research Chimps Being Retired

A Louisiana research center is sending more than 200 chimpanzees to a sanctuary in Georgia.

May 6, 2016
Tanya Lewis

FLICKR, AFRIKA FORCEThe University of Louisiana at Lafayette’s New Iberia Research Center (NIRC) has announced plans to relocate 220 research chimpanzees to a 236-acre sanctuary in Blue Ridge, Georgia, run by the nonprofit Project Chimps. The move is part of a growing effort to phase out research on these animals.

“We’re making history here,” Sarah Baeckler Davis, Project Chimps cofounder, president, and CEO, said in the statement. “We’re thrilled to partner with NIRC on this retirement of so many chimpanzees. It’s an unprecedented collaboration and a momentous occasion for chimpanzees.”

The chimps will be transferred in small social groups over the course of three to five years, starting with 10 animals in June, Davis said.

In 2013, the National Institutes of Health announced plans to retire most of its research chimpanzees and phase out most research on the animals. Last June, the U.S. Fish and Wildlife Service reclassified all U.S. chimps as endangered under the Endangered Species Act. And in November, the NIH announced plans to send its remaining chimps to sanctuaries.

Among the animals being transferred to the sanctuary are the chimps Hercules and Leo, which were part of a two-year legal battle over animal rights. They were originally slated to go to Save the Chimps, a Fort Pierce, Florida–based nonprofit. Nevertheless, the move is “good news, and it should be celebrated,” Molly Polidoroff, executive director of Save the Chimps, told Science

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.